- Home
- YIBO vs ABOS Comparison
YIBO vs ABOS Comparison
Compare YIBO & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YIBO
- ABOS
- Stock Information
- Founded
- YIBO 2011
- ABOS 1996
- Country
- YIBO China
- ABOS United States
- Employees
- YIBO N/A
- ABOS N/A
- Industry
- YIBO
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- YIBO
- ABOS Health Care
- Exchange
- YIBO NYSE
- ABOS Nasdaq
- Market Cap
- YIBO 75.4M
- ABOS 76.9M
- IPO Year
- YIBO 2024
- ABOS 2021
- Fundamental
- Price
- YIBO $1.23
- ABOS $1.10
- Analyst Decision
- YIBO
- ABOS Strong Buy
- Analyst Count
- YIBO 0
- ABOS 3
- Target Price
- YIBO N/A
- ABOS $7.33
- AVG Volume (30 Days)
- YIBO 26.4K
- ABOS 202.6K
- Earning Date
- YIBO 04-08-2025
- ABOS 03-27-2025
- Dividend Yield
- YIBO N/A
- ABOS N/A
- EPS Growth
- YIBO N/A
- ABOS N/A
- EPS
- YIBO 0.17
- ABOS N/A
- Revenue
- YIBO $153,281,000.00
- ABOS N/A
- Revenue This Year
- YIBO N/A
- ABOS N/A
- Revenue Next Year
- YIBO N/A
- ABOS N/A
- P/E Ratio
- YIBO $7.77
- ABOS N/A
- Revenue Growth
- YIBO 5.90
- ABOS N/A
- 52 Week Low
- YIBO $1.14
- ABOS $1.06
- 52 Week High
- YIBO $17.47
- ABOS $4.06
- Technical
- Relative Strength Index (RSI)
- YIBO 31.86
- ABOS 35.89
- Support Level
- YIBO $1.38
- ABOS $1.14
- Resistance Level
- YIBO $1.46
- ABOS $1.28
- Average True Range (ATR)
- YIBO 0.08
- ABOS 0.10
- MACD
- YIBO 0.03
- ABOS 0.00
- Stochastic Oscillator
- YIBO 0.00
- ABOS 9.52
About YIBO PLANET IMAGE INTERNATIONAL LIMITED
Planet Image International Ltd is engaged in manufacturing and selling compatible toner cartridges. It develops and manufactures toner cartridges that are compatible with, and can be used in, a wide range of commonly available models of laser printers from different manufacturers, or compatible toner cartridges, on a white-label or third-party brand basis or under its self-owned brands. The company also sells its branded products through online sales channels under three brands, TrueImage, CoolToner, and AZtech. The company operates in North America, Europe, and Other countries.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.